-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Sagimet Biosciences Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2022 to 2024.
- Sagimet Biosciences Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $105M.
- Sagimet Biosciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $105M, a 21.6% increase from 2023.
- Sagimet Biosciences Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $86.2M.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)